Login to Your Account



PhotoCure Shares Slide As FDA Says No To Metvix PDT

By Cormac Sheridan


Wednesday, December 8, 2004
PhotoCure ASA's efforts to obtain U.S. approval for its Metvix photodynamic therapy as a treatment for basal-cell carcinoma hit another roadblock last week, as FDA officials ruled that the clinical data submitted in its new drug application were insufficient for approval. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription